Abstracts

Dolutegravir Pharmacokinetics in HIV-Infected Pregnant and Postpartum Women

Dolutegravir (DTG), an integrase strand transfer inhibitor, is metabolized by UGT1A1 and CYP3A4. It has not been studied in pregnant women or infants. This study described DTG exposure during pregnancy compared to postpartum and in infant washout samples after delivery. IMPAACT protocol P1026s is an ongoing, nonrandomized, open-label, parallel-group, multi-center phase-IV prospective study of antiretroviral…

Prediction of Infant Exposure to Maternal Drugs From Breast Milk Using PBPK Modeling

Therapeutic drug use during lactation is widespread despite a paucity of data on breast milk excretion and the extent of breastfed infants’ exposure for many drugs. Physiologically-based pharmacokinetic (PBPK) modeling is increasingly used in paediatric studies, with significant regulatory support. Here we present for the first time the development and validation of a PBPK model…

Predicting Utility of Long-Acting Injectables in Paediatric Patients With PBPK Models

The use of long-acting (LA) ARVs in children and adolescents could be a valuable pharmacological option to simplify regimens, reduce drug costs and improve adherence. Dose optimisation in paediatric patients is complex and physiologically-based pharmacokinetic (PBPK) modelling represents a predictive tool to identify promising dosing strategies. The aim of this study was to simulate the…

Measurement of Integrated HIV DNA by Pulse-Field Gel Electrophoresis and ddPCR

Assays that measure the size of the latent reservoir with high sensitivity, precision and throughput are needed for clinical studies directed toward eradication. Droplet digital PCR (ddPCR) provides an efficient, standard-independent method to measure HIV DNA, but distinguishing between integrated and unintegrated molecular forms remains a challenge. Previous attempts to remove contaminating episomal and linear unintegrated…

Inhibition of the IN-LEDGF/p75 Interplay by LEDGINs Reduces Reactivation From Latency

Despite the success of cART, HIV-1 persists in a latent state in patients. Persistence is a consequence of proviral integration. LEDGF/p75 is the pivotal chromatin tethering factor targeting HIV integration into active transcription units through its interaction with HIV-1 integrase. We investigated the role of integration site selection in the establishment of HIV persistence employing…

HIV Infection in Astrocytes Via a CD4-Independent, CXCR4-Dependent Mechanism

HIV reservoir in the brain represents a major barrier for curing HIV infection. As the most abundant, long-lived cell type, astrocytes play a critical role in maintaining the reservoir; however the mechanism of infection remains unknown. Here, we determine how viral transmission occurs from HIV-infected lymphocytes to astrocytes.  Human astrocytes were exposed to HIV-infected lymphocytes…

A Unique In Vitro Neuropathic Phenotype of Clade D Transmitted/Founder Viruses

Expression of the anti-inflammatory, antioxidative phase II detoxifying enzyme heme oxygenase-1 (HO-1) is decreased in the brain prefrontal cortex of HIV+ individuals in association with increased neuroinflammation and neurocognitive impairment. In vitro HIV infection of monocyte-derived macrophages (MDM) induces HO-1 deficiency and increases release of neurotoxic levels of glutamate. We recently showed that HO-1 deficiency…